Dr Reddy’s halts worldwide supply of ranitidine
USFDA probing into the reported impurity N-nitrosodimethylamine in it at low levels
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Reddy’s
Indian’s big pharma companies finding new growth opportunities in China: Report
The Chinese pharma market is set to be worth $209 billion by 2022 Indian pharmaceutical companies are finding lucrative…
Notices issued to companies for introducing drugs without prior nod from NPPA: Government
The drugs include those used for treating conditions like diabetes, inflammation and chronic hepatitis C, among others
Dr Reddy’s launches insomnia treatment tablets in US
The company has launched Ramelteon tablets in the strength of 8 mg after getting approval from USFDA
Dr Reddy’s launches Tobramycin Inhalation Solutionin US Market
Dr Reddy’s Tobramycin Inhalation Solution, USP is available in a 300 mg/5 mL, single-dose Ampule
Dr Reddy’s and TR-Pharm in agreement
TR-Pharm will manufacture the drug substance and drug product upon completion of its facility investment in Turkey
Dr Reddy’s launches Nise D Spray
The spray will likely be effective in reducing inflammation and pain
DRL unveils new corporate brand identity
The new identity speaks of Dr Reddy’s constant endeavour to understand the unmet and under-met needs of patients, and the swift…